UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $1.00 per share CVR NYSE American (Trading privileges only, not registered) FORM 10-Q _________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly perio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________ 36-0904920 I.R.S. Employer Identification Number Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $1.00 per share CVR NYSE American (Trading privileges only, not registered) o ☒ ☐ FORM 10-Q _________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period end ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-01227 Chicago Rivet & Machine Co. (Exact name of registrant as specified in its charter) | --- | --- | |-----------------------------------------|-------------------------| | Illin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________ (Mark One) FORM 10-Q _________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ___________ Commission file number 000-01227 ___________________________ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _________________________________ (Mark One) FORM 10-Q _________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ___________ Commission file number 000-01227 ________________________________ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-----------------------------------------------------------------------------------------------|-----------------------------------------------------| | | | | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-01227 CHICAGO RIVET & MACHINE CO. (Exact name of registrant as specified in its charter) ILLINOIS 36-0904920 (State or other jurisdiction of incorporation or organization) (I.R.S. ...

PART I. FINANCIAL INFORMATION [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements.) Unaudited Q3 and YTD 2020 financials show decreased assets, equity, and net sales, shifting to a net loss, primarily due to COVID-19 impact [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of September 30, 2020, total assets decreased to **$31.44 million**, liabilities increased, and equity declined Condensed Consolidated Balance Sheet Summary | Balance Sheet Item | Sep 30, 2020 (Unaudited) | Dec 31, 2019 | | :--- | :--- | :--- | | Total Current Assets | $18,400,293 | $18,049,323 | | Net Property, Plant and Equipment | $13,034,794 | $13,674,053 | | **Total Assets** | **$31,435,087** | **$31,723,376** | | Total Current Liabilities | $2,225,564 | $1,622,265 | | **Total Liabilities** | **$3,096,648** | **$2,565,349** | | **Total Shareholders' Equity** | **$28,338,439** | **$29,158,027** | [Condensed Consolidated Statements of Income](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) Q3 2020 net sales were **$7.65 million** with stable net income, but YTD net sales fell, resulting in a **net loss** Income Statement Highlights (Unaudited) | Metric | Q3 2020 | Q3 2019 | Nine Months 2020 | Nine Months 2019 | | :--- | :--- | :--- | :--- | :--- | | Net Sales | $7,645,259 | $8,188,905 | $19,325,234 | $25,686,034 | | Gross Profit | $1,640,493 | $1,649,767 | $3,021,070 | $4,859,500 | | Operating Profit (Loss) | $381,498 | $367,618 | $(737,682) | $927,990 | | Net Income (Loss) | $309,135 | $315,797 | $(413,813) | $832,198 | | Net Income (Loss) Per Share | $0.32 | $0.32 | $(0.43) | $0.86 | - Cash dividends declared per share were significantly reduced to **$0.10** in Q3 2020 from **$0.22** in Q3 2019, and to **$0.42** for the nine-month period of 2020 from **$0.96** in the same period of 2019[18](index=18&type=chunk) [Condensed Consolidated Statements of Stockholders' Equity](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders'%20Equity) Shareholders' equity decreased from **$29.16 million** to **$28.34 million** by September 30, 2020, driven by net loss and dividends Change in Shareholders' Equity (YTD 2020) | Item | Amount | | :--- | :--- | | Balance, December 31, 2019 | $29,158,027 | | Net Loss (9 months) | $(413,813) | | Dividends Declared (9 months) | $(405,775) | | **Balance, September 30, 2020** | **$28,338,439** | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) YTD 2020 net cash from operations sharply declined to **$251,809**, resulting in a **net decrease of $431,623** in cash Cash Flow Summary (Nine Months Ended Sep 30) | Cash Flow Activity | 2020 | 2019 | | :--- | :--- | :--- | | Net cash provided by operating activities | $251,809 | $2,000,922 | | Net cash used in investing activities | $(277,657) | $(570,784) | | Net cash used in financing activities | $(405,775) | $(927,487) | | **Net (decrease) increase in cash** | **$(431,623)** | **$502,651** | [Notes to the Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20the%20Condensed%20Consolidated%20Financial%20Statements) Notes detail accounting policies, revenue by segment, COVID-19 impact, and a negative effective tax rate from the CARES Act - The company's business is concentrated in the fastener industry, serving primarily the automotive sector, with a geographic focus in the Midwestern United States[27](index=27&type=chunk)[29](index=29&type=chunk) Revenue by Segment (Nine Months Ended Sep 30) | Segment | 2020 | 2019 | | :--- | :--- | :--- | | Fastener | $17,275,555 | $22,702,719 | | Assembly Equipment | $2,049,679 | $2,983,315 | | **Total Net Sales** | **$19,325,234** | **$25,686,034** | - The COVID-19 pandemic had a significant negative impact on the company, particularly affecting automotive customers who idled operations[41](index=41&type=chunk) - In response to the pandemic, the company reduced expenses, delayed capital expenditures, and cut dividend payments[41](index=41&type=chunk) - The CARES Act allowed for the carryback of net operating losses, resulting in an effective tax rate of approximately **(32.7)%** for the nine months ended September 30, 2020, compared to **22.5%** in the prior year period[36](index=36&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=14&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations.) Management attributes the **24.8% YTD decline** in net sales and net loss to COVID-19's impact on automotive demand, with capital conservation measures [Results of Operations](index=14&type=section&id=Results%20of%20Operations) Net sales declined **6.6% in Q3** and **24.8% YTD** due to COVID-19, impacting Fastener and Assembly Equipment segments, with significant revenue declines Net Sales Performance | Period | 2020 | 2019 | Change (%) | | :--- | :--- | :--- | :--- | | Q3 | $7,645,259 | $8,188,905 | -6.6% | | YTD (9 Months) | $19,325,234 | $25,686,034 | -24.8% | - The Fastener segment's YTD revenues declined by **23.9% ($5.4 million)**, with sales to automotive and non-automotive customers down **25.5%** and **21.2%**, respectively[46](index=46&type=chunk) - The Assembly Equipment segment's YTD sales declined by **31.3% ($0.9 million)** due to the pandemic and the inclusion of high-value machine orders in 2019[47](index=47&type=chunk) [Liquidity and Capital Resources](index=15&type=section&id=Liquidity%20and%20Capital%20Resources) Working capital decreased to **$16.2 million** as of September 30, 2020, with capital conservation efforts including reduced dividends and capex - The quarterly dividend was reduced from **$0.22** to **$0.10** per share in the second quarter to conserve capital[52](index=52&type=chunk) - Capital expenditures were significantly reduced to **$375,657** for the first nine months of 2020, compared to **$1,562,784** in the same period of 2019[52](index=52&type=chunk) - Cash, cash equivalents, and certificates of deposit stood at **$7.5 million** as of September 30, 2020, down from **$8 million** at the beginning of the year[52](index=52&type=chunk) [Controls and Procedures](index=16&type=section&id=Item%204.%20Controls%20and%20Procedures.) Management concluded that disclosure controls and procedures were effective, with no material changes to internal control over financial reporting - The Chief Executive Officer and principal financial officer concluded that the company's disclosure controls and procedures were effective as of the end of the period covered by the report[57](index=57&type=chunk) - No changes occurred in the company's internal control over financial reporting during the fiscal quarter that have materially affected, or are reasonably likely to materially affect, these controls[58](index=58&type=chunk) PART II. OTHER INFORMATION [Item 6. Exhibits](index=17&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the quarterly report, including Sarbanes-Oxley Act certifications and the Interactive Data File (XBRL) - The exhibits filed with this report include certifications pursuant to Rule 13a-14(a) and 18 U.S.C. Section 1350 (Sarbanes-Oxley Act Sections 302 and 906)[59](index=59&type=chunk) - An Interactive Data File (XBRL) is included, containing the Condensed Consolidated Balance Sheets, Statements of Income, Stockholders' Equity, Cash Flows, and Notes to Financial Statements[59](index=59&type=chunk)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-----------------------------------------------------------------------------------------------|-----------------------------------------------------| | For th ...

Table of Contents Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ___________ Commission file number 000-01227 Chicago Rivet & Machine Co. (Exact Name of Registrant a ...